Author: Nichols Martin|| Date Published: March 26, 2019
Avon Protection Systems has received a five-year, $245.9M contract to produce and deliver M53A1 Chemical Biological Protective Mask systems to the U.S. Army.
The service branch solicited one bid for the firm-fixed-price contract and will assign performance locations and funds per order, the Department of Defense said Monday.
M53A1 is designed for use in military operations and deployable in air-purifying, powered air purifying and self-contained breathing modes.
The National Institute for Occupational Safety and Health has approved the M53A1 mask for domestic response missions.
DoD expects the company to finish contract work by March 24, 2024.
Virtualitics announced on LinkedIn Saturday that Nicole Diresta has been appointed vice president for public policy and planning. Diresta will oversee initiatives…
J2 Ventures has closed its $250 million Brookhaven Fund, an oversubscribed early-stage investment vehicle focused on dual-use technologies critical to…
The Department of Homeland Security’s Immigration and Customs Enforcement has started soliciting proposals for a potential two-year, $180 million contract…
The Department of Defense is conducting market research to assess industry capability and interest in supporting a planned indefinite-delivery/indefinite-quantity contract…
Avon Protection Systems has received a five-year, $245.9M contract to produce and deliver M53A1 Chemical Biological Protective Mask systems to the U.S. Army.
